PARTIAL LIPODYSTROPHY
Clinical trials for PARTIAL LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new PARTIAL LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for PARTIAL LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could blocking growth hormone ease severe insulin resistance?
Disease control Recruiting nowThis study tests a drug called pegvisomant in 25 adults with severe insulin resistance caused by lipodystrophy or insulin receptor gene changes. Participants give themselves daily shots for one month and have two short hospital stays for tests. The goal is to see if blocking grow…
Matched conditions: PARTIAL LIPODYSTROPHY
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New registry monitors Real-World safety of lipodystrophy drug metreleptin
Knowledge-focused Recruiting nowThis study is a registry that collects information from people with generalized or partial lipodystrophy who are taking the drug metreleptin. The goal is to track safety events like pancreatitis, liver problems, and infections in everyday medical practice. About 100 participants …
Matched conditions: PARTIAL LIPODYSTROPHY
Sponsor: Amryt Pharma • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC